Drugs Approved for Breast Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for breast cancer. The list includes generic and brand names. This page also lists common drug combinations used in breast cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in breast cancer that are not listed here.
Drugs Approved to Prevent Breast Cancer
Drugs Approved to Treat Breast Cancer
- Abemaciclib
- Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
- Ado-Trastuzumab Emtansine
- Afinitor (Everolimus)
- Anastrozole
- Aredia (Pamidronate Disodium)
- Arimidex (Anastrozole)
- Aromasin (Exemestane)
- Capecitabine
- Cyclophosphamide
- Docetaxel
- Doxorubicin Hydrochloride
- Ellence (Epirubicin Hydrochloride)
- Epirubicin Hydrochloride
- Eribulin Mesylate
- Everolimus
- Exemestane
- 5-FU (Fluorouracil Injection)
- Fareston (Toremifene)
- Faslodex (Fulvestrant)
- Femara (Letrozole)
- Fluorouracil Injection
- Fulvestrant
- Gemcitabine Hydrochloride
- Gemzar (Gemcitabine Hydrochloride)
- Goserelin Acetate
- Halaven (Eribulin Mesylate)
- Herceptin (Trastuzumab)
- Ibrance (Palbociclib)
- Ixabepilone
- Ixempra (Ixabepilone)
- Kadcyla (Ado-Trastuzumab Emtansine)
- Kisqali (Ribociclib)
- Lapatinib Ditosylate
- Letrozole
- Lynparza (Olaparib)
- Megestrol Acetate
- Methotrexate
- Neratinib Maleate
- Nerlynx (Neratinib Maleate)
- Olaparib
- Paclitaxel
- Paclitaxel Albumin-stabilized Nanoparticle Formulation
- Palbociclib
- Pamidronate Disodium
- Perjeta (Pertuzumab)
- Pertuzumab
- Ribociclib
- Talazoparib Tosylate
- Talzenna (Talazoparib Tosylate)
- Tamoxifen Citrate
- Taxol (Paclitaxel)
- Taxotere (Docetaxel)
- Thiotepa
- Toremifene
- Trastuzumab
- Trexall (Methotrexate)
- Tykerb (Lapatinib Ditosylate)
- Verzenio (Abemaciclib)
- Vinblastine Sulfate
- Xeloda (Capecitabine)
- Zoladex (Goserelin Acetate)
.png)
No hay comentarios:
Publicar un comentario